Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine pharmacogenetics during anesthesia in Pakistani surgical patients
IRCT20230824059251N1Phase 4Completed
- Sponsor
- Islamic International Medical College
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dexmedetomidine in None, sponsored by Islamic International Medical College. Primary endpoints: Sedation, Analgesia and 4 more. Started Sep 2023; status: completed.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on IRCT20230824059251N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230824059251N1.